Skip to main content
. Author manuscript; available in PMC: 2016 Sep 19.
Published in final edited form as: NPJ Breast Cancer. 2015 Oct 21;1:15014. doi: 10.1038/npjbcancer.2015.14

Figure 1. αB-crystallin expression is associated with worse breast cancer specific survival and distant relapse free survival in univariable analyses.

Figure 1

(A) Kaplan-Meier analysis of breast cancer specific survival based on αB-crystallin expression. 10-year breast cancer specific survival was 64% for αB-crystallin-positive cases (n = 359, number of events = 133) versus 75% for αB-crystallin-negative cases (n = 2870, number of events = 809), P < 0.0001 by log-rank test. (B) Kaplan-Meier analysis of distant relapse free survival based on αB-crystallin expression. 10-year distant relapse free survival was 62% for αB-crystallin-positive cases (n = 359, # of events = 139) versus 70% for αB-crystallin-negative cases (n = 2876, # of events = 915), P = 0.0016 by log-rank test.